Stevanato Group S.P.A. (STVN) Stock Price, Quote & News

Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delive...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 39 04 99 31 811

Website: www.stevanatogroup.com

Address:

Via Molinella 17, Piombino Dese, Italy

erevnon Mar. 5 at 3:15 PM

Keybanc maintains Stevanato Group $STVN at Overweight and lowers the price target from $37 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Turokk Mar. 4 at 9:21 PM

$ATON it will start going up + positive news coming out the 13th after the meeting. $ASNS $STVN $XPON

2 · Reply

OpenOutcrier Mar. 4 at 1:43 PM

$STVN (+8.6% pre) Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins https://ooc.bz/l/95453

0 · Reply

StocktwitsEarnings Mar. 4 at 1:27 PM

$STVN Q4 '25 Earnings Results & Recap Stevanato Group expects fiscal 2026 revenue between 1.26B and 1.29B, adjusted EBITDA from 331.8M to 346.9M, and adjusted diluted EPS in the range of 0.59 to 0.63.

0 · Reply

StockNews_Live Mar. 4 at 11:30 AM

$STVN Stevanato Group S.p.A. announced its financial results for the fourth quarter and full year 2025. Revenue increased 5% to €346.5 million, and high-value solutions represented 49% of total revenue. Gro…

0 · Reply

SuperGreenToday Feb. 12 at 8:07 PM

$STVN Share Price: $15.67 Contract Selected: Sep 18, 2026 $15 Calls Buy Zone: $0.77 – $0.95 Target Zone: $1.33 – $1.62 Potential Upside: 64% ROI Time to Expiration: 217 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

VWAPVandal Feb. 4 at 9:04 AM

$STVN European payment scale, integration execution important

0 · Reply

WellTodd Jan. 26 at 3:45 PM

$STVN what’s going on with this pos. Did it just have a big shake out or are we going lower still.

0 · Reply

OfficialStocktwitsUser Jan. 23 at 10:29 PM

$STVN RSI: 28.97, MACD: -0.7479 Vol: 1.07, MA20: 20.41, MA50: 21.31 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Arcides Jan. 23 at 7:50 PM

$STVN flushing....high volume

0 · Reply

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Mar 6, 2026, 4:28 AM EST - 9 days ago

Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story

Mar 4, 2026, 11:32 PM EST - 10 days ago

Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript

Mar 4, 2026, 6:30 AM EST - 11 days ago

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

Feb 19, 2026, 6:30 AM EST - 24 days ago

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

Jan 29, 2026, 1:22 PM EST - 6 weeks ago

Alger Small Cap Focus Fund Q4 2025 Portfolio Update

EXAS GH NBIS NTRA QURE

Jan 3, 2026, 12:10 PM EST - 2 months ago

Stevanato: Structural Growth Intact, Buy Confirmed

Nov 7, 2025, 3:06 AM EST - 4 months ago

Stevanato Group S.p.A. (STVN) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 6:30 AM EST - 4 months ago

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

Oct 31, 2025, 7:30 AM EDT - 4 months ago

Stevanato Group to Participate in Upcoming Investor Conferences

Oct 22, 2025, 6:30 AM EDT - 5 months ago

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 21, 2025, 6:30 AM EDT - 5 months ago

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

Sep 24, 2025, 9:23 AM EDT - 6 months ago

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 4:50 PM EDT - 6 months ago

Stevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 5, 2025, 6:30 AM EDT - 7 months ago

Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025

Jul 23, 2025, 6:30 AM EDT - 8 months ago

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

Jul 22, 2025, 4:30 PM EDT - 8 months ago

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 22, 2025, 1:39 PM EDT - 8 months ago

Stevanato: Expansion In Italy And The U.S. Will Pave The Way

Jun 22, 2025, 1:53 AM EDT - 9 months ago

Stevanato: Recovery Underway, Buy Confirmed

May 10, 2025, 4:45 PM EDT - 11 months ago

Stevanato Group S.p.A. (STVN) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:37 AM EDT - 11 months ago

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025

Apr 24, 2025, 5:15 PM EDT - 11 months ago

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 9, 2025, 2:37 PM EDT - 1 year ago

Stevanato: Ramping Syringe Demand, Buy Confirmed

Mar 6, 2025, 12:33 PM EST - 1 year ago

Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 6:31 AM EST - 1 year ago

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

Feb 24, 2025, 4:02 PM EST - 1 year ago

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

Jan 7, 2025, 4:30 PM EST - 1 year ago

Stevanato Group to Present at Upcoming Investor Conference

Nov 13, 2024, 1:18 AM EST - 1 year ago

Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement

Nov 11, 2024, 6:32 AM EST - 1 year ago

Stevanato Group to Present at Upcoming Investor Conferences

Nov 5, 2024, 2:10 PM EST - 1 year ago

Stevanato Group S.p.A. (STVN) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 6:31 AM EST - 1 year ago

Stevanato Group Reports Financial Results for the Third Quarter of 2024

Oct 22, 2024, 4:30 PM EDT - 1 year ago

Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024

Oct 1, 2024, 6:30 AM EDT - 1 year ago

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan

Sep 26, 2024, 7:04 AM EDT - 1 year ago

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Aug 10, 2024, 9:09 AM EDT - 1 year ago

Stevanato Group S.p.A. (STVN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 6:31 AM EDT - 1 year ago

Stevanato Group Reports Financial Results for the Second Quarter of 2024

Jul 25, 2024, 6:30 AM EDT - 1 year ago

Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

erevnon Mar. 5 at 3:15 PM

Keybanc maintains Stevanato Group $STVN at Overweight and lowers the price target from $37 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Turokk Mar. 4 at 9:21 PM

$ATON it will start going up + positive news coming out the 13th after the meeting. $ASNS $STVN $XPON

2 · Reply

OpenOutcrier Mar. 4 at 1:43 PM

0 · Reply

StocktwitsEarnings Mar. 4 at 1:27 PM

0 · Reply

StockNews_Live Mar. 4 at 11:30 AM

0 · Reply

SuperGreenToday Feb. 12 at 8:07 PM

0 · Reply

VWAPVandal Feb. 4 at 9:04 AM

$STVN European payment scale, integration execution important

0 · Reply

WellTodd Jan. 26 at 3:45 PM

$STVN what’s going on with this pos. Did it just have a big shake out or are we going lower still.

0 · Reply

OfficialStocktwitsUser Jan. 23 at 10:29 PM

0 · Reply

Arcides Jan. 23 at 7:50 PM

$STVN flushing....high volume

0 · Reply

BillionerOfKing Jan. 6 at 5:22 PM

$STVN Current Stock Price: $21.36 Contracts to trade: $22.5 STVN Jan 16 2026 Call Entry: $1.29 Exit: $2.33 ROI: 81% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BillionerOfKing Dec. 5 at 8:53 PM

$STVN Current Stock Price: $22.00 Contracts to trade: $20 STVN Dec 19 2025 Call Entry: $5.40 Exit: $10.14 ROI: 88% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JarvisFlow Dec. 2 at 5:56 PM

Morgan Stanley updates rating for Stevanato Group ( $STVN ) to Equal-Weight, target set at 26 → 24.

0 · Reply

JarvisFlow Nov. 11 at 4:56 PM

Morgan Stanley has updated their rating for Stevanato Group ( $STVN ) to Equal-Weight with a price target of 26.

0 · Reply

Findingthebull Oct. 7 at 3:41 PM

$STVN Added here. Will see if I timed it right.

0 · Reply

NVDAMillionaire Sep. 29 at 6:02 AM

$STVN Excellent article that nails exactly where STVN stands right now. So if you want to update your STVN knowledge or get acquainted with STVN, this is a must read. https://beyondspx.com/quote/STVN/analysis/stevanato-group-precision-expansion-and-biologics-drive-growth-nyse-stvn

0 · Reply

SteepDescent_ Aug. 20 at 10:03 PM

$STVN Last post from July. It's time to change that. under the radar for now but.. cleared all gates with margin (predicate_chain 0.74, link_pred 0.84, liquidity OK, financing OK) and matched the anchor theme. Evidence fit: timed RTU-cartridge adds for 2025–26 + clear GLP-1 pen overlap → clean predicate chain; plausible LTAs in 6–18 m. speculative buy 24m horizon, with p50 ≈2.1× and p90 ≈5.3×. Short window compresses upside.

0 · Reply

W15E Jul. 25 at 12:51 PM

$STVN has been a bit of a steady eddy

0 · Reply

W15E Jul. 11 at 1:50 AM

$STVN adding a bit more

0 · Reply

GrowthStreak Jun. 11 at 3:13 PM

$STVN

0 · Reply

W15E May. 17 at 5:59 AM

$STVN

0 · Reply

Market Cap	4.54B
Revenue (ttm)	1.34B
Net Income (ttm)	158.21M
EPS (ttm)	N/A
PE Ratio	24.98
Forward PE	20.80
Profit Margin	11.79%
Debt to Equity Ratio	0.32

Volume	494,600
Avg Vol	706,686
Day's Range	N/A - N/A
Shares Out	302.84M
Stochastic %K	24%
Beta	0.57
Analysts	Strong Sell
Price Target	$25.50